Evotec AG (EVT) - Financial and Strategic SWOT Analysis Review
July 2018
55
About the Report
About the Report
Evotec AG (EVT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory diseases. Evotec provides services such as integrated services, assay development and screening, reagent production services, ADMET, cellular target profiling, vitro pharmacology services and proteomics services. The company has long-term discovery alliances with several leading pharmaceutical companies and also has development partnerships for product candidates in clinical and pre-clinical development stages. The company has operating facilities in Abingdon and Manchester, the UK; Gottingen and Munich, Germany; South San Francisco, Branford and Princeton, the US; and Toulouse, France. Evotec is headquartered in Hamburg, Germany.
Evotec AG Key Recent Developments
Jul 04,2018: Sanofi integrates infectious disease unit into Evotec
Jun 25,2018: Evotec Achieves Second Milestone in Diabetes Alliance With Sanofi
May 31,2018: Arix Bioscience Forms Strategic Collaboration with Evotec AG and Fred Hutchinson Cancer Research Center to Foster New Companies in Cancer and Infectious Diseases
May 31,2018: Evotec forms academic BRIDGE 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center
May 09,2018: Evotec Reports First Quarter 2018 Results and Provides Corporate Update
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Evotec AG, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Pharmaceutical Product Development LLC
Covance Inc
Cobra Biologics Ltd
Charles River Germany GmbH & Co. KG
Almac Group Ltd
Albany Molecular Research Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Evotec AG-Key Facts 6
Evotec AG-Key Employees 7
Evotec AG-Key Employee Biographies 8
Evotec AG-Major Products and Services 9
Evotec AG-History 10
Evotec AG-Company Statement 19
Evotec AG-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Section 2-Company Analysis 22
Company Overview 22
Evotec AG-Business Description 23
Business Segment: EVT Execute Segment 23
Overview 23
Performance 23
Business Segment: EVT Innovate Segment 23
Overview 23
Performance 23
R&D Overview 24
Evotec AG-SWOT Analysis 25
SWOT Analysis-Overview 25
Evotec AG-Strengths 25
Evotec AG-Weaknesses 26
Evotec AG-Opportunities 27
Evotec AG-Threats 28
Evotec AG-Key Competitors 29
Section 3-Company Financial Ratios 30
Financial Ratios-Capital Market Ratios 30
Financial Ratios-Annual Ratios 31
Performance Chart 34
Financial Performance 34
Financial Ratios-Interim Ratios 35
Financial Ratios-Ratio Charts 36
Section 4-Company's Lifesciences Financial Deals and Alliances 37
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37
Evotec AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 38
Evotec AG, Recent Deals Summary 39
Section 5-Company's Recent Developments 40
Jul 04, 2018: Sanofi integrates infectious disease unit into Evotec 40
Jun 25, 2018: Evotec Achieves Second Milestone in Diabetes Alliance With Sanofi 41
May 31, 2018: Arix Bioscience Forms Strategic Collaboration with Evotec AG and Fred Hutchinson Cancer Research Center to Foster New Companies in Cancer and Infectious Diseases 42
May 31, 2018: Evotec forms academic BRIDGE 'LAB591' with Arix Bioscience and Fred Hutchinson Cancer Research Center 43
May 09, 2018: Evotec Reports First Quarter 2018 Results and Provides Corporate Update 44
May 02, 2018: Evotec Expands CRISPR-Based Technology Offering with Licence from ERS Genomics 46
Mar 27, 2018: Evotec plans conversion into European Company (SE) 47
Mar 26, 2018: Evotec Launches INDIGO, A Unique Integrated Drug Development Solution for Accelerating Early Drug Candidates into the Clinic 48
Feb 28, 2018: Novo Holdings announce Launch of REPAIR and formation of scientific selection board 49
Jan 08, 2018: Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi 50
Section 6-Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Figure
List of Figures
Evotec AG, Performance Chart (2013-2017) 34
Evotec AG, Ratio Charts 36
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37
Evotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 38
List of Table
List of Tables
Evotec AG, Key Facts 6
Evotec AG, Key Employees 7
Evotec AG, Key Employee Biographies 8
Evotec AG, Major Products and Services 9
Evotec AG, History 10
Evotec AG, Subsidiaries 20
Evotec AG, Joint Venture 21
Evotec AG, Key Competitors 29
Evotec AG, Ratios based on current share price 30
Evotec AG, Annual Ratios 31
Evotec AG, Annual Ratios (Cont...1) 32
Evotec AG, Annual Ratios (Cont...2) 33
Evotec AG, Interim Ratios 35
Evotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 37
Evotec AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 38
Evotec AG, Recent Deals Summary 39
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.